Improving lymphatic vessel function to treat lymphedema
Lymphatic Regeneration by Direct Cellular Reprogramming
This study is exploring a new way to help people with lymphedema by turning regular cells into special cells that can repair lymphatic vessels, aiming to offer a safer and more effective treatment option.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10841615 on NIH RePORTER |
What this research studies
This research focuses on developing a new method to regenerate lymphatic vessels, which are crucial for fluid balance and immune function in the body. By using a technique called direct cellular reprogramming, the researchers aim to convert regular cells into specialized lymphatic endothelial cells that can help alleviate conditions like lymphedema. This approach seeks to provide a more effective and safer treatment option compared to existing therapies, which are often limited and invasive. Patients may benefit from this innovative method that could lead to improved lymphatic function and reduced symptoms of lymphedema.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with lymphedema or those at risk of developing this condition due to lymphatic dysfunction.
Not a fit: Patients with lymphedema caused by irreversible damage or those who do not have functional lymphatic tissue may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel treatment option for patients suffering from lymphedema, potentially improving their quality of life.
How similar studies have performed: While direct cellular reprogramming is a relatively novel approach, preliminary studies have shown promise in similar applications for other conditions, indicating potential for success in this area.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Yoon, Young-Sup — Emory University
- Study coordinator: Yoon, Young-Sup
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.